Initiation of Smoking After Electroconvulsive Therapy in a Non-Smoker Patient with Major Depression: A Case Report

Document Type : Case Report(s)

Authors

1 Psychosomatic Research Center, Sari Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran

2 Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran

10.34172/ahj.1747

Abstract

Electroconvulsive therapy (ECT) is a well-established intervention for treatment-resistant major depressive disorder (MDD). Although the neurobiological ramifications of ECT, particularly in relation to the mesolimbic dopaminergic system, have been correlated with the modulation of reward and reinforcement pathways, the capacity of ECT to influence substance-related behaviors remains inadequately elucidated. We report the case of a 42-year-old Iranian woman with a 14-year history of treatment-resistant MDD and no prior history of tobacco or other substance use. Following a second session of inpatient ECT, the patient experienced a sudden and intense craving for cigarettes, leading to the immediate initiation of daily smoking. This pattern of tobacco use persisted for several years, despite multiple motivated attempts at cessation. The patient’s psychiatric management included standard pharmacotherapy and supportive interventions, but ongoing nicotine dependence remained challenging. There was no personal or family history of substance use, and no exposure to smoking in the inpatient setting, aside from a shared room with a smoker in a different ward. To our knowledge, this is the first documented case of cigarette smoking initiation following ECT in a non-smoking patient with MDD. The case underscores the need for heightened clinical vigilance and further investigation into ECT’s effects on addictive vulnerability and reward processing.

Highlights

Raheleh Rafaiee(Google scholar)(Pubmed)

Keywords

References

  1. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003;361(9360):799-808. doi:10.1016/ s0140-6736(03)12705-5
  2. Odermatt J, Sarlon J, Schaefer N, Ulrich S, Ridder M, Schneider E, et al. Electroconvulsive therapy reduces suicidality and all-cause mortality in refractory depression: a systematic review and meta-analysis of neurostimulation studies. Neurosci Appl 2025;4:105520. doi:10.1016/j.nsa.2025.105520
  3. Cojocaru AM, Vasile AI, Trifu SC. Neurobiological mechanisms and therapeutic impact of electroconvulsive therapy (ECT). Rom J Morphol Embryol 2024;65(1):13-7. doi:10.47162/ rjme.65.1.02
  4. Wade BS, Joshi SH, Njau S, Leaver AM, Vasavada M, Woods RP, et al. Effect of electroconvulsive therapy on striatal morphometry in major depressive disorder. Neuropsychopharmacology 2016;41(10):2481-91. doi:10.1038/npp.2016.48
  5. Michaelsen MM, Esch T. Understanding health behavior change by motivation and reward mechanisms: a review of the literature. Front Behav Neurosci 2023;17:1151918. doi:10.3389/fnbeh.2023.1151918
  6. Desfossés CY, Peredo R, Chabot A, Carmel JP, Tremblay PM, Mérette C, et al. The pattern of change in depressive symptoms and inflammatory markers after electroconvulsive therapy: a systematic review. J ECT 2021;37(4):291-7. doi:10.1097/ yct.0000000000000782
  7. Grelotti DJ, Kanayama G, Pope HG Jr. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry 2010;167(1):17-23. doi:10.1176/appi. ajp.2009.08111695
  8. Tavares AR, Volpe FM. Electroconvulsive therapy (ECT) effective for psychotic recrudescence and suicidality after varenicline adjunctive therapy for smoking cessation in a schizoaffective patient. Braz J Psychiatry 2010;32(3):315-6. doi:10.1590/s1516-44462010000300017
  9. Moss L, Vaidya N. Does comorbid alcohol and substance abuse affect electroconvulsive therapy outcome in the treatment of mood disorders? J ECT 2014;30(1):22-5. doi:10.1097/ YCT.0b013e31829aaeb8
  10. Ahmadi J, Ekramzadeh S, Pridmore S. Remission of methamphetamine-induced withdrawal delirium and craving after electroconvulsive therapy. Iran J Psychiatry Behav Sci 2015;9(4):e1793. doi:10.17795/ijpbs-1793
  11. Ziaaddini H, Roohbakhsh T, Nakhaee N, Ghaffari-Nejad A. Effectiveness of electroconvulsive therapy in persistent methamphetamine psychosis: a pilot study. Addict Health 2015;7(1-2):14-23.
  12. Picciotto MR, Kenny PJ. Mechanisms of nicotine addiction. Cold Spring Harb Perspect Med 2021;11(5):a039610. doi:10.1101/cshperspect.a039610
  13. Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R. Neurotransmitters and electroconvulsive therapy. J ECT 2014;30(2):116-21. doi:10.1097/yct.0000000000000138
  14. Subramanian S, Lopez R, Zorumski CF, Cristancho P. Electroconvulsive therapy in treatment resistant depression. J Neurol Sci 2022;434:120095. doi:10.1016/j.jns.2021.120095
  15. Salamone JD, Pardo M, Yohn SE, López-Cruz L, SanMiguel N, Correa M. Mesolimbic dopamine and the regulation of motivated behavior. Curr Top Behav Neurosci 2016;27:231- 57. doi:10.1007/7854_2015_383
  16. Modigh K, Balldin J, Edén S, Granérus AK, Wålinder J. Electroconvulsive therapy and receptor sensitivity. Acta Psychiatr Scand Suppl 1981;290:91-9. doi:10.1111/j.1600-0447.1981. tb00712.x
  17. Dannlowski U, Domschke K, Birosova E, Lawford B, Young R, Voisey J, et al. Dopamine D₃ receptor gene variation: impact on electroconvulsive therapy response and ventral striatum responsiveness in depression. Int J Neuropsychopharmacol 2013;16(7):1443-59. doi:10.1017/s1461145711001659
  18. Park SJ, Yi B, Lee HS, Oh WY, Na HK, Lee M, et al. To quit or not: vulnerability of women to smoking tobacco. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2016;34(1):33-56. doi:10.1080/10590501.2015.1131539
  19. Barrett SP. The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers. Behav Pharmacol 2010;21(2):144-52. doi:10.1097/ FBP.0b013e328337be68
  20. Perez Diaz M, Pochon JB, Ghahremani DG, Dean AC, Faulkner P, Petersen N, et al. Sex differences in the association of cigarette craving with insula structure. Int J Neuropsychopharmacol 2021;24(8):624-33. doi:10.1093/ ijnp/pyab015
  21. Wang M, Chen Y, Li H, Zhang X, Xu Y, Ding Z-H, et al. Association between psychiatric symptoms and craving in drug withdrawal. Int J Ment Health Addict 2023;21(5):3174- 84. doi:10.1007/s11469-022-00783-4
  22. Cepeda-Benito A, Reynoso JT, Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol 2004;72(4):712-22. doi:10.1037/0022-006x.72.4.712
  23. Xie H, Ma R, Yu M, Wang T, Chen J, Liang J, et al. History of tobacco smoking and alcohol use can predict the effectiveness of electroconvulsive therapy in individuals with schizophrenia: a multicenter clinical trial. J Psychiatr Res 2024;180:1-7. doi:10.1016/j.jpsychires.2024.09.045
Addiction & Health
Volume 18
Pages 1-4

Files

Share

How to cite

Statistics